Notch signaling regulates M2 type macrophage polarization during the development of proliferative vitreoretinopathy

Cellular Immunology

Volumn 298, Issue 1-2, 2015, Pages 77-82

  Zhang, Jingjing ^a   Zhou, Qingjun ^b   Yuan, Gongqiang ^a   Dong, Muchen ^b   Shi, Weiyun ^a,b  

^a SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG FIRST MEDICAL UNIVERSITY   (China)

^b SHANDONG EYE INSTITUTE   (China)

Author keywords

Macrophages; Notch signaling; Proliferative vitreoretinopathy; Retinal pigment epithelial cells; Wound healing

Indexed keywords

GAMMA SECRETASE INHIBITOR; VISUAL PIGMENT; ACTA2 PROTEIN, MOUSE; ACTIN; ARG1 PROTEIN, MOUSE; ARGINASE; CELL SURFACE RECEPTOR; DIPEPTIDE; LECTIN; MANNOSE BINDING LECTIN; MANNOSE RECEPTOR; N-(N-(3,5-DIFLUOROPHENACETYL)ALANYL)PHENYLGLYCINE TERT-BUTYL ESTER; NOTCH RECEPTOR; SECRETASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EPITHELIUM CELL; EXPERIMENTAL MODEL; MACROPHAGE; MEMBRANE; MOUSE; NONHUMAN; POLARIZATION; PRIORITY JOURNAL; VITREORETINOPATHY; ANIMAL; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; C57BL MOUSE; CELL POLARITY; CYTOLOGY; IMMUNOLOGY; INTRAVITREAL DRUG ADMINISTRATION; MACROPHAGE ACTIVATION; METABOLISM; PIGMENT EPITHELIUM; RANDOMIZATION; SIGNAL TRANSDUCTION;

ACTINS; AMYLOID PRECURSOR PROTEIN SECRETASES; ANIMALS; ARGINASE; CELL POLARITY; DIPEPTIDES; INTRAVITREAL INJECTIONS; LECTINS, C-TYPE; MACROPHAGE ACTIVATION; MACROPHAGES; MANNOSE-BINDING LECTINS; MICE; MICE, INBRED C57BL; RANDOM ALLOCATION; RECEPTORS, CELL SURFACE; RECEPTORS, NOTCH; RETINAL PIGMENT EPITHELIUM; SIGNAL TRANSDUCTION; VITREORETINOPATHY, PROLIFERATIVE;

EID: 84958642814     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2015.09.005     Document Type: Article

References (28)

1. Grigoropoulos V.G., Benson S., Bunce C., Charteris D.G. Functional outcome and prognostic factors in 304 eyes managed by retinectomy. Graefes Arch. Clin. Exp. Ophthalmol. 2007, 245:641-649.
2. Quiram P.A., Gonzales C.R., Hu W., Gupta A., Yoshizumi M.O., Kreiger A.E., Schwartz S.D. Outcomes of vitrectomy with inferior retinectomy in patients with recurrent rhegmatogenous retinal detachments and proliferative vitreoretinopathy. Ophthalmology 2006, 113:2041-2047.
3. Cordeiro M.F., Schultz G.S., Ali R.R., Bhattacharya S.S., Khaw P.T. Molecular therapy in ocular wound healing. Br. J. Ophthalmol. 1999, 83:1219-1224.
4. Agrawal R.N., He S., Spee C., Cui J.Z., Ryan S.J., Hinton D.R. In vivo models of proliferative vitreoretinopathy. Nat. Protoc. 2007, 2:67-77.
5. Lin M.L., Li Y.P., Li Z.R., Lin J.X., Zhou X.L., Liang D. Macrophages acquire fibroblast characteristics in a rat model of proliferative vitreoretinopathy. Ophthalmic Res. 2011, 45:180-190.
6. Sugg K.B., Lubardic J., Gumucio J.P., Mendias C.L. Changes in macrophage phenotype and induction of epithelial-to-mesenchymal transition genes following acute Achilles tenotomy and repair. J. Orthop. Res. 2014, 32:944-951.
7. Wang Y.C., He F., Feng F., Liu X.W., Dong G.Y., Qin H.Y., Hu X.B., Zheng M.H., Liang L., Feng L., et al. Notch signaling determines the M1 versus M2 polarization of macrophages in antitumor immune responses. Cancer Res. 2010, 70:4840-4849.
8. Wilson A., Radtke F. Multiple functions of Notch signaling in self-renewing organs and cancer. FEBS Lett. 2006, 580:2860-2868.
9. Zhu F., Li T., Qiu F., Fan J., Zhou Q., Ding X., Nie J., Yu X. Preventive effect of Notch signaling inhibition by a gamma-secretase inhibitor on peritoneal dialysis fluid-induced peritoneal fibrosis in rats. Am. J. Pathol. 2010, 176:650-659.
10. Schouwey K., Aydin I.T., Radtke F., Beermann F. RBP-Jkappa-dependent Notch signaling enhances retinal pigment epithelial cell proliferation in transgenic mice. Oncogene 2011, 30:313-322.
11. Chen X., Xiao W., Liu X., Zeng M., Luo L., Wu M., Ye S., Liu Y. Blockade of Jagged/Notch pathway abrogates transforming growth factor beta2-induced epithelial-mesenchymal transition in human retinal pigment epithelium cells. Curr. Mol. Med. 2014, 14:523-534.
12. Noseda M., McLean G., Niessen K., Chang L., Pollet I., Montpetit R., Shahidi R., Dorovini-Zis K., Li L., Beckstead B., et al. Notch activation results in phenotypic and functional changes consistent with endothelial-to-mesenchymal transformation. Circ. Res. 2004, 94:910-917.
13. Leask A. Targeting the jagged/notch pathway: a new treatment for fibrosis?. J. Cell Commun. Signal. 2010, 4:197-198.
14. Wang Z., Li Y., Kong D., Sarkar F.H. The role of Notch signaling pathway in epithelial-mesenchymal transition (EMT) during development and tumor aggressiveness. Curr. Drug Targets 2010, 11:745-751.
15. He F., Guo F.C., Li Z., Yu H.C., Ma P.F., Zhao J.L., Feng L., Li W.N., Liu X.W., Qin H.Y., et al. Myeloid-specific disruption of recombination signal binding protein Jkappa ameliorates hepatic fibrosis by attenuating inflammation through cylindromatosis in mice. Hepatology 2014.
16. Qi X., Cai J., Ruan Q., Liu L., Boye S.L., Chen Z., Hauswirth W.W., Ryals R.C., Shaw L., Caballero S., et al. Gamma-secretase inhibition of murine choroidal neovascularization is associated with reduction of superoxide and proinflammatory cytokines. Invest. Ophthalmol. Vis. Sci. 2012, 53:574-585.
17. Outtz H.H., Tattersall I.W., Kofler N.M., Steinbach N., Kitajewski J. Notch1 controls macrophage recruitment and Notch signaling is activated at sites of endothelial cell anastomosis during retinal angiogenesis in mice. Blood 2011, 118:3436-3439.
18. Lei H., Rheaume M.A., Cui J., Mukai S., Maberley D., Samad A., Matsubara J., Kazlauskas A. A novel function of p53: a gatekeeper of retinal detachment. Am. J. Pathol. 2012, 181:866-874.
19. Miller W., Makova K.D., Nekrutenko A., Hardison R.C. Comparative genomics. Annu. Rev. Genomics Hum. Genet. 2004, 5:15-56.
20. Zahn G., Volk K., Lewis G.P., Vossmeyer D., Stragies R., Heier J.S., Daniel P.E., Adamis A.P., Chapin E.A., Fisher S.K., et al. Assessment of the integrin alpha5beta1 antagonist JSM6427 in proliferative vitreoretinopathy using in vitro assays and a rabbit model of retinal detachment. Invest. Ophthalmol. Vis. Sci. 2010, 51:1028-1035.
21. Wickham L.J., Asaria R.H., Alexander R., Luthert P., Charteris D.G. Immunopathology of intraocular silicone oil: retina and epiretinal membranes. Br. J. Ophthalmol. 2007, 91:258-262.
22. Martin F., Pastor J.C., De La Rua E.R., Mayo-Iscar A., Garcia-Arumi J., Martinez V., Fernandez N., Saornil M.A. Proliferative vitreoretinopathy: cytologic findings in vitreous samples. Ophthalmic Res. 2003, 35:232-238.
23. Garweg J.G., Tappeiner C., Halberstadt M. Pathophysiology of proliferative vitreoretinopathy in retinal detachment. Surv. Ophthalmol. 2013, 58:321-329.
24. Biswas S.K., Mantovani A. Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm. Nat. Immunol. 2010, 11:889-896.
25. Gordon S. Alternative activation of macrophages. Nat. Rev. Immunol. 2003, 3:23-35.
26. Kobayashi Y., Yoshida S., Nakama T., Zhou Y., Ishikawa K., Arita R., Nakao S., Miyazaki M., Sassa Y., Oshima Y., et al. Overexpression of CD163 in vitreous and fibrovascular membranes of patients with proliferative diabetic retinopathy: possible involvement of periostin. Br. J. Ophthalmol. 2014.
27. Xiao W., Chen X., Liu X., Luo L., Ye S., Liu Y. Trichostatin A, a histone deacetylase inhibitor, suppresses proliferation and epithelial-mesenchymal transition in retinal pigment epithelium cells. J. Cell Mol. Med. 2014.
28. Zhang W., Xu W., Xiong S. Blockade of Notch1 signaling alleviates murine lupus via blunting macrophage activation and M2b polarization. J Immunol 2010, 184:6465-6478.